Is it necessary to stop antiplatelet agents before a native renal biopsy?

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3566-3570

  Mackinnon, Bruce ^a   Fraser, Emily ^b   Simpson, Keith ^a   Fox, Jonathan G ^a   Geddes, Colin ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Bleeding; Bleeding time; Complications; Renal biopsy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; HEMOGLOBIN; PROCOAGULANT;

ADULT; AGED; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD TRANSFUSION; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULTRASOUND;

ADULT; AGED; BIOPSY, NEEDLE; BLEEDING TIME; COHORT STUDIES; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 54149107496     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn282     Document Type: Article

References (20)

1. Doyle AJ, Gregory MC, Terreros DA. Percutaneous native renal biopsy: comparison of a 1.2-mm spring-driven system with a traditional 2-mm hand-driven system. Am J Kidney Dis 1994; 23: 498-503
2. Nyman RS, Cappelen-Smith J, al Suhaibani H et al. Yield and complications in percutaneous renal biopsy. A comparison between ultrasound-guided gun-biopsy and manual techniques in native and transplant kidneys. Acta Radiol 1997; 38: 431-436
3. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens 2004; 13: 661-665
4. Nelson CL, Mackinnon MWB, Charleasworth JA. The importance of renal biopsy. Nephrology (Carlton) 2001; 6: 270-273
5. Peterson P, Hayes TE, Arkin CF et al. The preoperative bleeding time test lacks clinical benefit: college of American pathologists' and American society of clinical pathologists' position article. Arch Surg 1998; 133: 134-139
6. Hergesell O, Felten H, Andrassy K et al. Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 1998; 13: 975-977
7. Manno C, Strippoli GF, Arnesano L et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66: 1570-1577
8. Mattix H, Singh AK. Is the bleeding time predictive of bleeding prior to a percutaneous renal biopsy? Curr Opin Nephrol Hypertens 1999; 8: 715-718
9. Stiles KP, Hill C, LeBrun CJ et al. The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsies. J Nephrol 2001; 14: 275-279
10. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-2674
11. Burger W, Chemnitius JM, Kneissl GD et al. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257: 399-414
12. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-1317
13. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93: 573-580
14. Covic A, Schiller A, Volovat C et al. Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transplant 2006; 21: 419-424
15. Rychlik I, Jancova E, Tesar V et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant 2004; 19: 3040-3049
16. Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15: 142-147
17. Lowe GD. Desmopressin and myocardial infarction. Lancet 1989; 1: 895-896
18. Stratton J, Warwicker P, Watkins S et al. Desmopressin may be hazardous in thrombotic microangiopathy. Nephrol Dial Transplant 2001; 16: 161-162
19. Herth FJ, Becker HD, Ernst A. Aspirin does not increase bleeding complications after transbronchial biopsy. Chest 2002; 122: 1461-1464
20. Ferrari E, Benhamou M, Cerboni P et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-459